Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Post Info TOPIC: European Commission Grants Marketing Authorizations for AbbVie's VIEKIRAX + EXVIERA


Guru

Status: Offline
Posts: 5629
Date:
European Commission Grants Marketing Authorizations for AbbVie's VIEKIRAX + EXVIERA
Permalink  
 


NORTH CHICAGO, Ill., Jan. 16, 2015 -- AbbVie announced that the European Commission has granted marketing authorizations for its all-oral, short-course, interferon-free treatment of VIEKIRAX  (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA  (dasabuvir tablets).

The treatment has been approved with or without ribavirin (RBV) for patients with genotype 1 chronic hepatitis C virus (HCV) infection, including those with compensated liver cirrhosis, HIV-1 co-infection, patients on opioid substitution therapy and liver transplant recipients.

Additionally, VIEKIRAX has been approved for use with RBV in genotype 4 chronic hepatitis C patients.

"The approval of AbbVie's hepatitis C treatment in the European Union, following the recent approvals in the U.S. and Canada, offers patients across Europe a new and effective treatment to cure this serious disease," said Richard Gonzalez, chairman of the board and chief executive officer, AbbVie.  "We are committed to working with local governments and healthcare systems to support broad access to VIEKIRAX + EXVIERA."


Full press release...

http://abbvie.mediaroom.com/2015-01-16-European-Commission-Grants-Marketing-Authorizations-for-AbbVies-VIEKIRAX-ombitasvir-paritaprevir-ritonavir-tablets-EXVIERA-dasabuvir-tablets-for-the-Treatment-of-Chronic-Hepatitis-C

 

 

 

 

 



__________________

Jill 

(71 yo, lives in UK)

Was Gen 3a, 

24wks Peg Ifn/Riba, Sep 2010 - Mch 2011

UND @ Wk.4, UND @ EOT, 

SVR Nov 2011 --> Still UND @ EOT + 4 yrs.

 

 

Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.

Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.